Dermapharm Holding SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A2GS5D8
EUR
38.00
1 (2.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
572.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
572.42
Raw Material Cost
790.67
792.49
654.54
545.53
540.42
486.68
391.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
281.11
265.74
185.43
165.99
159.28
117.13
92.26
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
63.39
59.55
13.87
9.85
10.61
10.89
7.57
Selling and Distribution Expenses
171.18
131.89
96.17
112.62
95.65
88.35
66.29
Other Expenses
-33.30
-31.47
-18.61
-16.17
-15.72
-11.68
-9.29
Total Expenditure (Excl Depreciation)
973.38
935.00
763.89
672.32
648.73
586.24
464.59
Operating Profit (PBDIT) excl Other Income
207.39999999999998
200.3
260.9
270.59999999999997
145.1
114.60000000000001
107.8
Other Income
24.70
18.72
10.76
20.48
3.12
4.63
5.33
Operating Profit (PBDIT)
322.58
323.66
372.82
354.48
200.94
170.88
140.21
Interest
63.39
59.55
13.87
9.85
10.61
10.89
7.57
Exceptional Items
1.79
-46.36
-27.94
3.62
-14.38
1.32
-6.09
Gross Profit (PBDT)
390.10
342.86
370.23
397.38
253.41
214.20
181.09
Depreciation
90.50
104.59
101.18
55.60
49.17
50.12
24.11
Profit Before Tax
170.49
113.16
229.84
292.65
126.79
111.18
102.44
Tax
60.27
45.46
83.68
84.07
39.36
32.25
29.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.79
62.37
134.24
209.58
85.83
77.20
75.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.79
62.37
134.24
209.58
85.83
77.20
75.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.05
-1.83
-1.62
-0.68
0.10
0.62
-0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
111.74
60.53
132.62
208.90
85.93
77.81
75.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
604.42
539.21
531.59
497.32
321.97
278.65
252.45
Earnings per share (EPS)
2.11
1.16
2.49
3.89
1.59
1.43
1.41
Diluted Earnings per share
2.11
1.16
2.49
3.89
1.59
1.43
1.41
Operating Profit Margin (Excl OI)
17.56%
17.65%
25.46%
29.53%
18.73%
16.57%
19.35%
Gross Profit Margin
22.1%
19.18%
32.3%
36.93%
22.17%
23.01%
22.11%
PAT Margin
9.64%
5.49%
13.1%
22.23%
10.81%
11.01%
13.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 4.00% vs 10.79% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 84.63% vs -54.37% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -2.30% vs -15.80% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 6.55% vs 328.06% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Dermapharm Holding SE With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
1,180.77
796.97
383.80
48.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,180.77
796.97
383.80
48.16%
Raw Material Cost
790.67
731.11
59.56
8.15%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
281.11
458.74
-177.63
-38.72%
Power Cost
0
0
0.00
Manufacturing Expenses
63.39
11.70
51.69
441.79%
Selling and Distribution Expenses
171.18
140.10
31.08
22.18%
Other Expenses
-33.30
-37.36
4.06
10.87%
Total Expenditure (Excl Depreciation)
973.38
968.01
5.37
0.55%
Operating Profit (PBDIT) excl Other Income
207.39
-171.04
378.43
221.25%
Other Income
24.70
39.66
-14.96
-37.72%
Operating Profit (PBDIT)
322.58
-29.77
352.35
1,183.57%
Interest
63.39
11.70
51.69
441.79%
Exceptional Items
1.79
-93.44
95.23
101.92%
Gross Profit (PBDT)
390.10
65.86
324.24
492.32%
Depreciation
90.50
101.62
-11.12
-10.94%
Profit Before Tax
170.49
-236.53
407.02
172.08%
Tax
60.27
-44.76
105.03
234.65%
Provisions and contingencies
0
0
0.00
Profit After Tax
113.79
-196.08
309.87
158.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.79
-196.08
309.87
158.03%
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.05
0.00
-2.05
Other related items
0.00
0.00
0.00
Consolidated Net Profit
111.74
-196.08
307.82
156.99%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
604.42
952.52
-348.10
-36.55%
Earnings per share (EPS)
2.11
-1.11
3.22
290.09%
Diluted Earnings per share
2.11
-1.11
3.22
290.09%
Operating Profit Margin (Excl OI)
17.56%
-21.46%
0.00
39.02%
Gross Profit Margin
22.10%
-16.93%
0.00
39.03%
PAT Margin
9.64%
-24.60%
0.00
34.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 118.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.00% vs 10.79% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 11.17 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 84.63% vs -54.37% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.79 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.30% vs -15.80% in Dec 2023

Annual - Interest
Interest 6.34 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.55% vs 328.06% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.56%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023